11. FINAL DIAGNOSIS
SYSTEMIC HYPERTENSION
ACUTE CORONARY SYNDROME
ANTERO LATERAL MYOCARDIAL INFARCTION
TWO VESSEL DISEASE
MODERATE LV SYSTOLIC DYSFUNCTION
12. DRUG CHART
DAY 1
Conscious,Oriented
BP :150/90mmHg
PR :100b/m
Primary PTCA stenting to LAD
CLOPIDOGREL loading dose 300mg
T.CLOPIDOGREL 75mg 1-0-1
T.ECOSPRIN 325mg 0-1-0
T.CARLOC 3.125mg 1/2-0-1/2
T.PANTOPRAZOLE 40mg 1-0-0
T.SORBITRATE 5mg 1-1-1
AGGRAMED INFUSION 6m/hr
T.NIKORAN 5 mg 1-0-1
INJ HEPARIN 8000 IU/ml
DAY 2
PR : 90/Min
BP : 120/80 mmHg
IP/OP : 1100/700 ml
T.CLOPIDOGREL 75mg 1-0-1
T.ECOSPRIN 325mg 0-1-0
T.CARDIVAS 3.125mg 1/2-0-1/2
T.PANTOPRAZOLE 40mg 1-0-0
NIKORAN 5 mg
INJ HEPARIN 4000 IU/ml
T. RAMIPRIL 2.5mg 1-0-0
T. IVABRADINE 5 mg 1-0-1
13. DAY 3
BP : 130/80
PR : 100/Min
IP/OP :1480/1650 ml
SAME AS DAY 2
DAY 4
BP : 110/70
PR : 80/Min
IP/OP : 1700/1500ml
ANGIOGRAM DONE
ABOVE DRUGS+
ECOSPIRIN 150mg 0-1-0
CLOPIDOGRL 1-0-0
DAY 5
BP : 110/70
PR : 72/Min
IP/OP : 1700/1500ml
PLANNED ELECTIVE PTCA
SAME AS DAY 4
14. DAY 6
BP : 110/70
PR : 64
IP/OP : 1600/1000
S/P ELECTIVE PTCA WITH STENTING
TO RCA
SAME AS DAY 4
DAY 7
BP : 100/60
PR : 60/Min
SAME AS DAY 4
17. SUBJECTIVE
A 52 year old male patient admitted with Chest pain since 2 days
& Aggravation at morning.
OBJECTIVE
k/c/o Systemic hypertension
BP : 150/90
PR :100/Min
Rhythm : normal
S1 , S2 : normal
18. ECG reports shows that the patient has anterolateral MI
ECHOCARDIOGRAPHY : CAD , Regional Wall Motion Abnormalities ( Antero-lateral wall
hypokinetic) , LV systolic dysfunction (EF=35%) concentric LVH, mild MR
ASSESSMENT
Based on the subjective evidences the patient is diagnosed to have
myocardial infarction
21. DISCUSSION
MYOCARDIAL INFARCTION
A diseased condition caused by reduced blood flow in a coronary artery due to
atherosclerosis and occlusion of an artery by thrombus. It is the rapid development of
myocardial necrosis by a critical imbalance between oxygen supply and demand to the
myocardium.
CAUSES
REGARDING DISEASE
Rupture of an atherosclerotic lesion within coronary wall
Coronary artery vasospasm
Ventricular hypertrophy
Hypoxia
Coronary artery emboli
Increased afterload which increases myocardial demand
22. RISK FACTORS
Age
Male gender
Smoking
Hypercholesterolemia and triglyceridemia
Diabetes Mellitus
Poorly controlled hypertension
Family History
Sedentary lifestyle
HYPERTENSION
condition in which the blood pressure in the arteries is persistently elevated. It is a major risk factor
for coronary artery disease, stroke, heart failure, peripheral vascular disease.
23. For the reduction of atherosclerotic events like MI and stroke.
MOA: Inhibitor of platelet aggregation , selectively inhibits binding of ADP to
its receptor.
Taken with or without food.
ADR: GI bleeding, rashes , diarrhoea, abdominal pain.
CI :Hypersensitivity, Use during hemorrhagic disorders causes GI bleeding.
T.CLOPIDOGREL ( CLOPILET75 mg )
REGADING MEDICATION
24. Antiplatelet agent.
MOA : It inhibits cyclooxygenase, which is responsible for the synthesis of
prostaglandin and thromboxane. It also inhibits platelet aggregation.
ADR:GI bleeding ,thrombocytopenia,bleeding disorders, rashes .
CI: hypersensitivity,G6PD deficiency , hepatic impairment , GI lesions etc.
T.ASPIRIN (ECOSPIRIN150 mg)
25. CARVEDILOL (CARDIVAS 3.125MG)
CATEGORY: Antihypertensive, anti-anginal
MOA : Binds to beta adrenergic receptors , inhibition of these receptors leads to
deceased heart rate & contractility
CI: Bronchial asthma, cardiogenic shock, bradycardia
ADR: Hypotension, edema, rash, pruritis, hyperkalemia
26. NICORANDIL (NIKORAN 5MG)
CATEGORY: Vasodilator
MOA: stimulates formation of cyclic GMP, which activates protein kinase G &
decreases Ca sensitivity of smooth muscle
CI : hypersensitivity
ADR: headache, skin ulcer, palpitations, vomiting
27. RAMIPRIL (2.5mg)
CATEGORY: ACE inhibitor, antihypertensive
DOSE: 2.5mg orally od
MOA: inhibit ACE, lowering pdtn of angiotensin II, causes relaxation of arteriole
smooth muscle & decrease in peripheral resistance
CI: Angioedema, renal impairment
ADR: hypotension, dry cough, hyperkalemia
29. • MOA : Degrade tissue macrophages and inactivate clotting factor x.
• ADR ; Bleeding disorder, thrombocytopenia,rarely hypersensitivity,
hyperkalaemia.
• CI : Severe hypertension,bleeding disorders, cirrhosis, renal failure
• DI : Cephalosporin : increased risk of bleeding.
Nitroglycerin : efficacy of heparin decreased.
Penicillin : addictive effects on heparin,increased risk of bleeding.
INJ. HEPARIN4000 IU
30. Tab. PANTOP (Pantoprazole 40mg)
-Indication:GERD,Peptic ulcer
- Proton pump inhibitor, Reduces gastric acid secretion
-Special precaution:Long term use may lead to bacterial overgrowth in GI
tract and hepatic impairment
-ADR:Diziness,pruritis,skin rashes,GI tract infection
31. T.isosorbide dinitrate (SORBITRATE 5mg)
CATEGORY: Nitrates
MOA: It works by relaxing & widening blood vessels so blood can
flow more easily to the heart.
USES :Heart failure, esophageal spasms, prevent chest pain in
patients with certain heart conditions.
SE: Headaches, dizziness, nausea, flushing.
32. Patient Counselling Points
REGARDING DISEASE
Maintain a low cholesterol diet.
Substitution of non-hydrogenated saturated fat & trans fat in the
diet.
Conception of omega3 fatty acids (primary source is fish).
33. BLOOD PRESSURE CHECKED : high blood pressure (hypertension) is a
major risk factor for heart attack .
normal BP is 120/80mmHg.
CHOLESTEROL CHECKED : As high risk for MI, LDL “Bad” Cholesterol
should be lower than 100mg/dl.
WEIGHT MANAGEMENT: BMI between 18.5-24.9kg/m2.
34. REGARDING DRUGS
Tab.Ecospirin
- High dose long term therapy causes GI bleeding
- Take drug with food or after meal to avoid GI upset
- Keep out of reach of children
•INJ HEPARIN
- Inform doctor or dentist or other health care providers of heparin
therapy.
- take advise consulting prescriber before taking any other drugs
including OTC drugs
35. TAB.CLOPIDOGREL
- It may take longer to stop bleeding;retrain from activities in which trauma and bleeding may
occur
- Care should be taken while driving
- Inform doctor or dentist of clopidogrel use before scheduling surgery or taking new drug
PANTOPRAZOLE (PANTOCID 40 mg)
•Do not miss the doss
•Take the drug 30 min before food
•May cause diarrhea, dizziness, pruiritis , skin rashes
•Tablet should not be chewed or crushed
36. TAB.CARVEDILOL 3.125 mg
Take tablet either with or without food, but try to take doses at the same time of
day .
Do not take two doses together to make up for a forgotten dose.
Eat healthy diet , do not smoke & take regular exercise.
TAB. NICORANDIL 5MG
Take one tablet twice daily, in the morning & evening.
Take tablets either before or after meals.
Swallow the tablet with a drink of water.
37. TAB. RAMIPRIL 2.5 MG
The 1st dose may make you feel dizzy, so it is best taken at bed time.
Commonly taken as once daily dose.
Take tablet either with or without food.
Patient should avoid potassium containing supplements while taking this drug.
Tell patient to report signs/symptoms of angioedema (deep swelling around
eyes/lips and sometimes hands and feet)
38. Aspirin and Clopidogrel are interacted with Heparin.Moniter closely
C-reactive proteins and troponin values are not checked.
Heparin and pantoprazole may increase risk for osteoporosis hence
multivitamin tablets should be given.
Normally Aspirin 150 is administered for patients with CAD or anginal pain but
here Aspirin 325 is given.
Clopidogrel is supposed to be given once a day but in this case it is given twice.
PHARMACISTS
INTERVENTION